All News about Intellia Thera CS
![](https://cdn.benzinga.com/files/images/story/2023/04/13/image_4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/ARK_Photo_by_Ira_Lichi_on_Shutterstock.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Where Intellia Therapeutics Stands With Analysts
March 31, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2021/01/crispr-stocks.jpg)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Intellia Therapeutics
March 14, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600a.jpg)
![](https://g.foolcdn.com/editorial/images/723141/growth-chart.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/724894/scientists-in-a-lab-smiling.jpg)
![](https://g.foolcdn.com/editorial/images/723427/dna-on-monitor-scientists.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Intellia Therapeutics Earnings Perspective: Return On Capital Employed
February 28, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/723341/advisor-reviewing-data-on-a-laptop-with-a-family.jpg)
![](https://investorplace.com/wp-content/uploads/2022/03/cathie-wood-stocks-1600.png)
![](https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2023/03/02/stock_chart_higher.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/01/Stock-intelliatherapeutics-01-adobe.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230222073259_3-mid-cap-biotechs-the-street-sees-doubling.jpg)
![](https://g.foolcdn.com/editorial/images/721399/dna-genetic-sequencing-biotech-1.jpg)
![](https://g.foolcdn.com/editorial/images/720699/dna-research-concept.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_123.jpeg?width=1200&height=800&fit=crop)
![](https://optimize.foolcdn.com/?url=https%3A%2F%2Fg.foolcdn.com%2Fmisc-assets/jester.png&w=400&op=resize)
![](https://g.foolcdn.com/editorial/images/718384/scientists-in-a-lab-smiling.jpg)
![](https://i0.wp.com/raygent.com/wp-content/uploads/2023/02/image.png)
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2023/02/01/edit_logo_light__796db60d07928674d783a74bde03fba4.png?width=1200&height=800&fit=crop)
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
February 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2531.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.